PlantEXT is a leading pharmaceutical cannabis research and product development company, driven by a team of world-class experts in research and development and product commercialization. With a true pharma approach, PlantEXT utilizes its extensive knowledge and experience in the pharmaceutical industry to develop the most effective and clinically evidenced medical cannabis formulations. They are dedicated to improving the quality of life for patients worldwide.

PlantEXT's innovative approach is rooted in Israel, the global leader in cannabis research, and Canada, the pioneer of the cannabis capital market. This strategic positioning allows them to leverage the rich array of research and knowledge from these countries, giving them a competitive advantage based on years of experience. Their team of experts, including renowned auditors, researchers, scientists, and medical professionals, ensure that the highest quality, safe, and effective medical cannabis solutions are developed to meet unmet needs in the market.

By acquiring exclusive global rights to commercialize the intellectual property and methodology of the Agricultural Research Organization of Israel, PlantEXT has developed active and anti-inflammatory formulations of cannabinoids and terpenes derived from cannabis. Their research has identified synergistic combinations of these compounds to reduce inflammation in various diseases. If you're interested in joining their mission or learning more, you can reach out to PlantEXT through their website or contact them directly